Vault-13

Iron Triangle Partners LP

Cos Cob, CT · CIK 1779763 · 13F filing filed 2026-02-17

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$874.7m reported value +24.4% vs Q3 2025
27positions
53.2%in top 10
16 new 8 added 3 reduced 14 sold out vs Q3 2025

Holdings, Q4 2025

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 CHARLES RIV LABS INTL INC COM CRL CRL 379,728 $75.7m8.66% 8.66% AddedShares held: Q1 2025 0, Q2 2025 320.0k, Q3 2025 268.0k, Q4 2025 379.7k +111.7k +111,728 41.7%
2 INTUITIVE SURGICAL INC COM NEW ISRG ISRG 94,459 $53.5m6.12% 6.12% NewShares held: Q1 2025 30.0k, Q2 2025 60.0k, Q3 2025 0, Q4 2025 94.5k
3 REPLIGEN CORP COM RGEN RGEN 320,474 $52.5m6.00% 6.00% AddedShares held: Q1 2025 0, Q2 2025 0, Q3 2025 270.0k, Q4 2025 320.5k +50.5k +50,474 18.7%
4 JAZZ PHARMACEUTICALS PLC SHS USD JAZZ JAZZ 292,170 $49.7m5.68% 5.68% AddedShares held: Q1 2025 130.0k, Q2 2025 0, Q3 2025 150.0k, Q4 2025 292.2k +142.2k +142,170 94.8%
5 VERACYTE INC COM VCYT VCYT 980,391 $41.3m4.72% 4.72% AddedShares held: Q1 2025 0, Q2 2025 0, Q3 2025 485.0k, Q4 2025 980.4k +495.4k +495,391 102.1%
6 BOSTON SCIENTIFIC CORP COM BSX BSX 420,773 $40.1m4.59% 4.59% NewShares held: Q1 2025 332.2k, Q2 2025 0, Q3 2025 0, Q4 2025 420.8k
7 WATERS CORP COM WAT WAT 105,167 $39.9m4.57% 4.57% NewShares held: Q1 2025 0, Q2 2025 0, Q3 2025 0, Q4 2025 105.2k
8 BROOKDALE SR LIVING INC COM BKD BKD 3,491,663 $37.7m4.31% 4.31% AddedShares held: Q1 2025 0, Q2 2025 1.7m, Q3 2025 2.8m, Q4 2025 3.5m +653.3k +653,302 23.0%
9 ELI LILLY & CO COM LLY LLY 35,045 $37.7m4.31% 4.31% ReducedShares held: Q1 2025 0, Q2 2025 0, Q3 2025 49.6k, Q4 2025 35.0k -14.5k -14,510 -29.3%
10 BRUKER CORP COM BRKR BRKR 794,380 $37.4m4.28% 4.28% NewShares held: Q1 2025 0, Q2 2025 0, Q3 2025 0, Q4 2025 794.4k
11 VERTEX PHARMACEUTICALS INC COM VRTX VRTX 76,910 $34.9m3.99% 3.99% NewShares held: Q1 2025 0, Q2 2025 0, Q3 2025 0, Q4 2025 76.9k
12 CVS HEALTH CORP COM CVS CVS 432,457 $34.3m3.92% 3.92% ReducedShares held: Q1 2025 0, Q2 2025 750.0k, Q3 2025 797.9k, Q4 2025 432.5k -365.4k -365,443 -45.8%
13 FORTREA HLDGS INC COMMON STOCK FTRE FTRE 1,986,333 $34.3m3.92% 3.92% NewShares held: Q1 2025 0, Q2 2025 0, Q3 2025 0, Q4 2025 2.0m
14 MERIT MED SYS INC COM MMSI MMSI 385,660 $34.0m3.89% 3.89% NewShares held: Q1 2025 229.7k, Q2 2025 392.8k, Q3 2025 0, Q4 2025 385.7k
15 BRIGHTSPRING HEALTH SVCS INC COM BTSG BTSG 897,427 $33.6m3.84% 3.84% ReducedShares held: Q1 2025 722.3k, Q2 2025 1.2m, Q3 2025 1.2m, Q4 2025 897.4k -341.1k -341,093 -27.5%
16 DOXIMITY INC CL A DOCS DOCS 686,568 $30.4m3.48% 3.48% AddedShares held: Q1 2025 360.0k, Q2 2025 471.3k, Q3 2025 210.0k, Q4 2025 686.6k +476.6k +476,568 226.9%
17 BIO-TECHNE CORP COM TECH TECH 467,409 $27.5m3.14% 3.14% NewShares held: Q1 2025 250.0k, Q2 2025 0, Q3 2025 0, Q4 2025 467.4k
18 ALPHATEC HLDGS INC COM NEW ATEC ATEC 1,285,685 $27.1m3.09% 3.09% NewShares held: Q1 2025 0, Q2 2025 0, Q3 2025 0, Q4 2025 1.3m
19 ADAPTHEALTH CORP COMMON STOCK AHCO AHCO 2,609,003 $26.0m2.97% 2.97% AddedShares held: Q1 2025 1.6m, Q2 2025 1.9m, Q3 2025 1.9m, Q4 2025 2.6m +684.9k +684,871 35.6%
20 ENVISTA HOLDINGS CORPORATION COM NVST NVST 1,186,704 $25.8m2.95% 2.95% NewShares held: Q1 2025 1.2m, Q2 2025 620.0k, Q3 2025 0, Q4 2025 1.2m
21 UNITEDHEALTH GROUP INC COM UNH UNH 70,126 $23.1m2.65% 2.65% NewShares held: Q1 2025 0, Q2 2025 0, Q3 2025 0, Q4 2025 70.1k
22 ABBOTT LABS COM ABT ABT 175,333 $22.0m2.51% 2.51% NewShares held: Q1 2025 0, Q2 2025 0, Q3 2025 0, Q4 2025 175.3k
23 IDEAYA BIOSCIENCES INC COM IDYA IDYA 467,484 $16.2m1.85% 1.85% AddedShares held: Q1 2025 0, Q2 2025 0, Q3 2025 270.0k, Q4 2025 467.5k +197.5k +197,484 73.1%
24 BIOHAVEN LTD COM BHVN BHVN 958,336 $10.8m1.24% 1.24% NewShares held: Q1 2025 0, Q2 2025 0, Q3 2025 0, Q4 2025 958.3k
25 XENON PHARMACEUTICALS INC COM XENE XENE 233,688 $10.5m1.20% 1.20% NewShares held: Q1 2025 0, Q2 2025 0, Q3 2025 0, Q4 2025 233.7k
26 DIANTHUS THERAPEUTICS INC COM DNTH DNTH 230,730 $9.5m1.09% 1.09% NewShares held: Q1 2025 0, Q2 2025 0, Q3 2025 0, Q4 2025 230.7k
27 MINERALYS THERAPEUTICS INC COM MLYS MLYS 257,085 $9.3m1.07% 1.07% NewShares held: Q1 2025 0, Q2 2025 0, Q3 2025 0, Q4 2025 257.1k

Sold out since Q3 2025

SecurityTickerShares held beforeValue then
DEXCOM INC DXCM DXCM 850,000 $57.2m850.0k shares
ABBVIE INC ABBV ABBV 200,326 $46.4m200.3k shares
MEDTRONIC PLC MDT MDT 453,347 $43.2m453.3k shares
GLAUKOS CORP GKOS GKOS 342,804 $28.0m342.8k shares
TENET HEALTHCARE CORP THC THC 137,448 $27.9m137.4k shares
EXACT SCIENCES CORP EXAS EXAS 500,000 $27.4m500.0k shares
ADAPTIVE BIOTECHNOLOGIES COR ADPT ADPT 1,820,915 $27.2m1.8m shares
MADRIGAL PHARMACEUTICALS INC MDGL MDGL 58,378 $26.8m58.4k shares
GUARDANT HEALTH INC GH GH 400,000 $25.0m400.0k shares
CARDINAL HEALTH INC CAH CAH 138,011 $21.7m138.0k shares
NEUROCRINE BIOSCIENCES INC NBIX NBIX 131,390 $18.4m131.4k shares
WEST PHARMACEUTICAL SVSC INC WST WST 70,000 $18.4m70.0k shares
AMICUS THERAPEUTICS INC FOLD FOLD 1,971,260 $15.5m2.0m shares
ARGENX SE ARGX ARGX 9,900 $7.3m9.9k shares